about
DEAR1 is a dominant regulator of acinar morphogenesis and an independent predictor of local recurrence-free survival in early-onset breast cancerCHD8 associates with human Staf and contributes to efficient U6 RNA polymerase III transcriptionCHD5, a brain-specific paralog of Mi2 chromatin remodeling enzymes, regulates expression of neuronal genesA small-cell lung cancer genome with complex signatures of tobacco exposureThe genomic complexity of primary human prostate cancerMolecular and phenotypic aspects of CHD7 mutation in CHARGE syndromeDefects in neural stem cell proliferation and olfaction in Chd7 deficient mice indicate a mechanism for hyposmia in human CHARGE syndromeChromodomain-helicase-DNA binding protein 5, 7 and pronecrotic mixed lineage kinase domain-like protein serve as potential prognostic biomarkers in patients with resected pancreatic adenocarcinomasSingle and Multiple Gene Manipulations in Mouse Models of Human CancerChromodomain helicase DNA-binding proteins in stem cells and human developmental diseasesATP-dependent chromatin remodeling complexes as novel targets for cancer therapyRole of CHD5 in human cancers: 10 years laterPlant Homeodomain (PHD) Fingers of CHD4 Are Histone H3-binding Modules with Preference for Unmodified H3K4 and Methylated H3K9The genomic landscapes of human breast and colorectal cancersDeubiquitylase OTUD3 regulates PTEN stability and suppresses tumorigenesisSmall RNAs analysis in CLL reveals a deregulation of miRNA expression and novel miRNA candidates of putative relevance in CLL pathogenesisA microRNA component of the p53 tumour suppressor networkSyntenic relationships between genomic profiles of fiber-induced murine and human malignant mesotheliomaConvergence of mutation and epigenetic alterations identifies common genes in cancer that predict for poor prognosisCHD5 is required for spermiogenesis and chromatin condensationChd5 requires PHD-mediated histone 3 binding for tumor suppressionRole of chromodomain helicase DNA-binding protein 2 in DNA damage response signaling and tumorigenesisTransactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosisAssessing the significance of chromosomal aberrations in cancer: methodology and application to gliomaThe ATP-dependent chromatin remodeling enzyme CHD7 regulates pro-neural gene expression and neurogenesis in the inner ear.DEAR1 is a chromosome 1p35 tumor suppressor and master regulator of TGF-β-driven epithelial-mesenchymal transitionLoss of NOTCH2 positively predicts survival in subgroups of human glial brain tumorsA constitutional translocation t(1;17)(p36.2;q11.2) in a neuroblastoma patient disrupts the human NBPF1 and ACCN1 genesmicroRNAs join the p53 network--another piece in the tumour-suppression puzzle.Mutation screening of CHD5 in melanoma-prone families linked to 1p36 revealed no deleterious coding or splice site changes.Exploratory analysis of the copy number alterations in glioblastoma multiforme.A new tumor suppressor that regulates tissue architecture.Distinct high-profile methylated genes in colorectal cancerGenetic signature of adult gliomas and correlation with MRI features.A p53-dependent mechanism underlies macrocytic anemia in a mouse model of human 5q- syndrome.Chromatin remodeling in development and disease: focus on CHD7.Differential expression and sex chromosome association of CHD3/4 and CHD5 during spermatogenesisDeletion of the Chd6 exon 12 affects motor coordination.miR-34a functions as a tumor suppressor modulating EGFR in glioblastoma multiformeUse of chromosome engineering to model a segmental deletion of chromosome band 7q22 found in myeloid malignancies.
P2860
Q21092361-91310690-915E-41B4-93F1-292A7F69578AQ24297872-DB15014E-15B8-413A-8DAE-6A691A3BFB1AQ24338318-79C77BAE-72E4-4E95-9F0D-B6B373A75E89Q24600510-8363178A-7100-4722-BE52-9683AA717AE2Q24617949-3DBAB8E3-3450-432B-96A0-DF6BD9A26842Q24634411-D97ADF27-E3EC-4A1A-A926-FA357D0225FFQ24648502-856B487E-9B1C-4066-B604-DE017C539587Q26751724-0D2F1A42-4C4D-4545-9F9A-358F53C0EA6FQ26783920-3D70E18D-9D78-44C9-B373-C892A17AEA6CQ26822979-D394A0CE-CF48-43BE-8416-37A90CA07170Q26849467-112C0635-3C9D-4022-A656-DA0F446012B4Q27006929-E9C82EE6-57EC-4800-8C2B-679711C4A834Q27666769-760DCF55-1E77-46B5-B521-3AB5B7678E6DQ27861078-AF1249CB-5DC1-418C-AE56-C4C3FF82ABF9Q28117749-62024D59-7723-4B7B-9745-2F4104C27E34Q28256626-526C1F4A-CBCF-4757-9D08-2A5308771FC8Q28305330-CFC8CD9A-C693-4633-8A3F-FA61DCE199FFQ28387443-1CBB9529-D5C6-4910-B180-C4F7039B530DQ28472991-DFD62CEA-D59D-4243-B2AF-BDD621D1202DQ28510857-965826B6-4B2A-4230-A9C1-D7477F9EB2F0Q28593132-87DD4A21-6DAE-4D05-BE54-D99C30ADAD5BQ28594458-DF3E0F6B-9F41-4580-90F8-86CDA24C772EQ29547575-882C705C-00D3-4C0D-B6DE-F53B891FBC89Q30014823-7CDD3BCE-C74D-4A97-8DBC-F2ABECFEEA4EQ30474131-C6F252F2-C50A-4FE4-9567-26EDD36BA4EBQ30584686-E1837F26-B041-4049-8016-14CEFD33DD34Q33288968-1E95F0C8-011E-4935-84FE-BBB628254DCCQ33336547-E3827C70-1F96-44F6-9BFA-4F06807F2311Q33344707-DC449A68-F842-43E8-BC95-044A96FA2AB1Q33370678-59690F95-8A91-4689-B1AA-1223E68C496FQ33396458-FCC64446-73A8-4F8D-9EB0-147FA01863D5Q33470281-2DC0A735-F9B7-43C0-9863-002AC9852A3CQ33502762-83DCF326-1AA7-478C-8D12-8AB798A68550Q33509600-84ADF8FC-94A5-48A6-BA5F-56E01C92FE7DQ33579912-5EF0DB38-EF96-4C1C-9DE9-17D8632E3951Q33640084-78E65FDC-F320-470E-93CB-F4CF93D1B1BCQ33646049-47C33151-2B43-432E-9F50-049480996A18Q33751230-D671EF95-F5B7-4EB3-852D-785977766EA7Q33856653-A741C448-27E2-473D-8B89-17319DBB070FQ33896721-6A3FEF2F-6922-452E-A38B-9C46A5DABF45
P2860
description
2007 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2007
@ast
im Februar 2007 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2007/02/09)
@sk
vědecký článek publikovaný v roce 2007
@cs
wetenschappelijk artikel (gepubliceerd op 2007/02/09)
@nl
наукова стаття, опублікована в лютому 2007
@uk
مقالة علمية (نشرت في 9-2-2007)
@ar
name
CHD5 is a tumor suppressor at human 1p36
@ast
CHD5 is a tumor suppressor at human 1p36
@en
CHD5 is a tumor suppressor at human 1p36
@nl
type
label
CHD5 is a tumor suppressor at human 1p36
@ast
CHD5 is a tumor suppressor at human 1p36
@en
CHD5 is a tumor suppressor at human 1p36
@nl
prefLabel
CHD5 is a tumor suppressor at human 1p36
@ast
CHD5 is a tumor suppressor at human 1p36
@en
CHD5 is a tumor suppressor at human 1p36
@nl
P2093
P1433
P1476
CHD5 is a tumor suppressor at human 1p36
@en
P2093
Alea A Mills
Anindya Bagchi
Cristian Papazoglu
Dailia Francis
Daniel Capurso
Markus Bredel
Michael Brodt
P304
P356
10.1016/J.CELL.2006.11.052
P407
P577
2007-02-01T00:00:00Z